MoMs Hips a Grinding Dilemma for Hospitals, Doctors, FDA
But all hell broke lose four years ago when a raft of failure and toxicity issues surfaced among patients who had received two major MoM devices sold under the name DePuy, the ASR Acetabular System, and the ASR Hip Resurfacing System, both manufactured by Johnson & Johnson. In a statement announcing it was recalling these devices in 2010, DePuy officials acknowledged that 12% to 13% of patients required revision surgery after five years.
Class action lawsuits tumbled in.
Then more complaints and concerns came flooding in from many more patients, including many who received other MoM protheses made by five manufacturers. Many patients, like Steve Lorenz of Whitehall, PA, said that when they told their doctors that they weren't recovering from their hip surgeries, but were getting worse, they were brushed off.
"He disregarded every symptom, and then he equated what happened to him when he took a Pilates class with his wife," recalls Lorenz' wife, Pat, who testified before the FDA panel about the surgeon's reaction to her husband's complaints.
How did hundreds of thousands of potentially unsafe devices get into the market?
- Ratcheting Up Patient Experience Has a Downside
- 12 Hires to Keep Your Hospital Out of Trouble
- Meaningful Use Payment Adjustments Begin
- 'Mega Boards' Could be Rural Healthcare Disruptor
- HL20: Lee Aase—Who's Behind @MayoClinic
- Taming Time and Moving Healthcare Data
- HL20: Anne Wojcicki—Unlocking Consumer Access to Genetics
- Narrow Networks Enjoying a Resurgence
- Top 3 Nursing Lessons of 2014
- 1 in 5 Eligible Hospitals Penalized for HACs